<address id="aecd"><address id="aecd"><ol id="aecd"><li id="aecd"></li></ol></address></address>

    <q id="aecd"><kbd id="aecd"></kbd></q><tt id="aecd"></tt>
              <p id="aecd"><code id="aecd"><kbd id="aecd"><strong id="aecd"></strong></kbd></code></p>


              PDX模型

              来源于患者原代肿瘤组织的肿瘤移植模型(Patient-derived xenograft模型PDX模型)为临床前药效的评估以及生物标志物的鉴定提供了有效的研发资源。与使用细胞系建立的肿瘤模型相比PDX模型减少了体外培养步骤保持临床肿瘤细胞的形态和分子生物学特征因而用该模型做出的药效结果将更为准确与临床试验结果更为接近。金斯瑞拥有多种PDX模型并拥有数十株人原代肿瘤细胞系。


              • Tumor Model Progress
              • Passages
              • Case Study
              • Genotyping Analysis

              Major Tumor Types Other Tumor Types
              Liver cancer
              Bladder cancer, Breast cancer
              Lung cancer 
              Uterine cancer, Pancreatic cancer

              Kidney cancer

              Small intestine cancer
              Gastric cancer
              Ovarian cancer, Gallbladder cancer 
              Colorectal cancer
              Head and neck cancer
              Esophageal cancer
              Thyroid cancer
              Brain cancer
              Mediastinal tumor, etc


              Figure1. Human primary tumor model establishment (gastric cancer). The tumors from the sequential passages (from P0 stage to P3 stage) show identical histopathological characteristics.



              Figure1. Patient-derived human primary tumor model of lung cancer shows the anti-cancer effects of Sutent on tumor growth and tumor weight.



              询价与订购

              为了能够准确高效地为您提供报价请您首先下载并完整服务询价表然后将填写完整的询价表通过邮件发给我们我们将第一时间为您提供报价。